España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tidal Trust III VistaShares Artificial Intelligence Supercycle ETF
AIS
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$25.55
1.00
4.07%
Pre-Market: Dec 9, 8:06 AM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Tidal Trust III VistaShares Artificial Intelligence Supercycle ETF (ARCA:AIS)
Tidal Trust III VistaShares Artificial Intelligence Supercycle ETF (ARCA: AIS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 06, 2012
Antares Pharma Announces Move to the NASDAQ Stock Market
Benzinga
Thursday, April 26, 2012
Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
Benzinga
Friday, March 16, 2012
Antares Pharma Spikes Higher on Positive Seeking Alpha Article
Benzinga
Tuesday, March 13, 2012
Oppenheimer Maintains Antares Pharma at Outpe...
Benzinga
Monday, March 12, 2012
Earnings Scheduled For March 12
Benzinga
Sunday, March 11, 2012
Earnings Expectations for the Week of March 12 (URBN, ROST)
Benzinga
Tuesday, January 17, 2012
Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals for Oxybutynin Gel 3% in South Korea
Benzinga
Tuesday, December 20, 2011
Antares Pharma Enters Licensing Agreement with Pfizer Consumer Healthcare
Benzinga
Thursday, December 08, 2011
Financial Breakfast: Morning News Summary for December 8, 2011
Benzinga
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Benzinga
Monday, December 05, 2011
Antares Pharma Hits 52-Week High of $2.86
Benzinga
Tuesday, November 29, 2011
Antares Pharma Announces Issuance of New U.S. Patent Covering LibiGel
Benzinga
Wednesday, November 16, 2011
Biotech Watchlist: BioSante Pharmaceuticals and Antares Pharma
Benzinga
Tuesday, October 04, 2011
Antares Pharma Granted New U.S. Patent Covering VIBEX Injector Technology
Benzinga
Thursday, August 04, 2011
Antares Pharma Announces Positive Study Results with VIBEX MTX in Rheumatoid Arthritis Patients
Benzinga
Monday, July 25, 2011
Stocks to Watch This Week and Potential Trades to Make
Benzinga
Monday, July 11, 2011
Antares Pharma and Watson Pharmaceuticals Ann...
Benzinga
Tuesday, July 05, 2011
3 High Momentum Stocks to Watch This Week
Benzinga
Monday, June 13, 2011
Stocks to Watch for 6/13/11: Fresh 52-Week Highs and Lows
Benzinga
Friday, June 10, 2011
Stocks to Watch 6/10/11: Fresh 52-Week Highs and Lows
Benzinga
Friday, May 13, 2011
Antares Pharma 12.5M Share Public Offering Priced at $1.60 per Share
Benzinga
Thursday, May 12, 2011
Antares Pharma Announces Proposed Public Offering of Common Stock
Benzinga
Monday, May 02, 2011
CEOWORLD Top Medical Equipment and Supplies stocks- ELOS, FLDM, SURG, WWIN, KH, OSUR, AIS, TRNX, DCTH, ICUI
Benzinga
Friday, April 08, 2011
Antares Pharma Trading Higher Pre-Market (AIS)
Benzinga
Antares Pharma Announces FDA Acceptance of Anturol NDA for Filing
Benzinga
Antares Pharma Announces FDA Acceptance For Filing (AIS)
Benzinga
Tuesday, March 29, 2011
Software Radio Technology tracks down new contract wins in China
Benzinga
Monday, March 14, 2011
Antares Pharma Reports EPS of $(0.02) vs. $(0.02)
Benzinga
Earnings Scheduled For March 14 (JST, DOLE, MEMS, AIS, ZAGG, CPE, TNDM, GPOR, CHDN, OPTT, ULTR, IRET, GVP, PRST)
Benzinga
Monday, February 14, 2011
Antares Pharma Announces Receipt of NDA User Fee Waiver
Benzinga
BioSante Pharmaceuticals Higher On "Female Viagra" Trial Results (BPAX)
Benzinga
Wednesday, January 12, 2011
Antares Pharma to Initiate Clinical Trial of VIBEX
Benzinga
Monday, December 06, 2010
Good News for Medtronic - Analyst Blog
Benzinga
Good News for Medtronic - Analyst Blog
Benzinga
Thursday, November 11, 2010
Antares Reports In Line - Analyst Blog
Benzinga
Friday, September 17, 2010
Antares Pharma Announces Departure of Senior VP
Benzinga
Tuesday, April 06, 2010
Monday's Hot Stocks on Heavier Volume
Benzinga